RxDoctor Payments Data

Hardildar Gill, MD

Psychiatry · Richland, WANPI 1356785406

Payments from drug & device makers

$1,341in general payments, 2019–2025

Across 76 payments — averaging $17.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$560
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$151
  • Neurocrine Biosciences, Inc.$149
  • E.r. Squibb & Sons, L.L.C.$108
  • Johnson & Johnson$100
  • AbbVie$69
  • plus $204 from 6 others

What the payments were for

  • Food & beverage$1,20190%
  • Education$14010%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,341 in reported general payments places this provider in the 85th percentile of 576 psychiatry providers in Washington.

See all psychiatry providers in Washington

Medicare billing

Part B allowed, 2024
$86,071
Medicare patients
80
Services billed
808

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate56$186,863
Abilify MaintenaAripiprazole30$76,430
AustedoDeutetrabenazine11$63,831
RexultiBrexpiprazole11$14,928
Divalproex Sodium ErDivalproex Sodium213$10,877
Lurasidone Hcl50$8,482
Clozapine184$6,966
Paliperidone ErPaliperidone38$6,225
Clomipramine Hcl17$4,762
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine44$4,220
Ziprasidone Hcl36$2,874
Quetiapine Fumarate249$2,679
Olanzapine171$2,299
Haloperidol66$2,193
Bupropion XlBupropion Hcl99$2,049

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$100$186,86356 claims
Teva Pharmaceuticals USA, Inc.Austedo$61$63,83111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 576 psychiatry providers in Washington.

Other psychiatry in Richland

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →